Elisabeth Pharmacon Ltd. was founded by Czech biologist Dr. Omar Sery and businessman Petr Cermak in London (2012). Company sells DNA diagnostics under EliGene® brand name and PCR workstation under brand name Zephyrus.
Elisabeth Pharmacon Ltd. is the member of the international group Elisabeth Pharmacon Group. Elisabeth Pharmacon spol. s.r.o. headquartered in the Czech Republic is also its member.
This company cooperates with many scientific research institutes and clinics. From the moment of its foundation the Czech company cooperated with the Faculty of Science of Masaryk University. It became the first Czech company producing DNA diagnostics according to EN ISO 13485:2012 certificate in 2008. Systems of quality EN ISO 13485:2003 and EN ISO 9001:2008 cover all types of activities such as project development, development, production, purchase, storage and sales of medical devices and medical tools for in vitro diagnostics and molecular-biological trials, measurement and analysis. The aim is to offer product of the highest quality at the best affordable price in the market.
HLA-B27 is the main immunogenetic marker of high predisposition to development of ankylosing spondylitis (Bekhterev’s disease) and other related seronegative spondyloarthropathies.